Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
BMC Cancer|October 21, 2018
Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective studySatoshi Shiba, Hiroshi Imaoka, Kazuhiko Shioji, et al.
BMC Cancer|October 2, 2020
Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort studyHiroshi Imaoka, Masafumi Ikeda, Kosuke Maehara, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 19, 2021
Risk stratification and prognostic factors in patients with unresectable undifferentiated carcinoma of the pancreasHiroshi Imaoka, Masafumi Ikeda, Kosuke Maehara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[Gemcitabine treatment in patients with stage IV pancreatic cancer and prognostic factors for survival of patients with stage IVb(a retrospective survey at 15 hospitals in Niigata Prefecture)]Hironobu Ohta, Kazuhiko Shioji, Yuzuru Maruyama, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 21, 2025
Depth of response in patients with locally advanced pancreatic cancer treated with first-line chemotherapy: A supplementary analysis of JCOG1407Taro Shibuki, Masafumi Ikeda, Masayuki Yokoyama, et al.
Pancreas|December 28, 2020
Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma: Potential Efficacy of Platinum- and Irinotecan-Containing RegimensHideaki Takahashi, Masafumi Ikeda, Satoshi Shiba, et al.
Japanese Journal of Clinical Oncology|June 16, 2023
Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatmentHiroshi Imaoka, Masafumi Ikeda, Kumiko Umemoto, et al.
International Journal of Clinical Oncology|June 15, 2020
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study)Naohiro Okano, Chigusa Morizane, Shogo Nomura, et al.
Cancers|June 12, 2026
Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic ConsiderationsHiroshi Imaoka, Masafumi Ikeda, Masashi Wakabayashi, et al.
Japanese Journal of Clinical Oncology|June 6, 2024
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22Hiroshi Imaoka, Keita Sasaki, Ryunosuke Machida, et al.
Pageof 3